Researchers reviewed up to three years of health records after participants began taking either a GLP-1 receptor agonist, most commonly semaglutide, liraglutide, or dulaglutide, or an SGLT2 inhibitor, another type of diabetes medication
This will guide your initial visit
Everything about this program has been great so far, and Im hopeful and excited to keep going
Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists
While the precise mechanism of NAION remains unknown, the effects of GLP-1 on vascular function, glucose homeostasis, and neuroprotection may potentially influence NAION development
By 2024, more than 645,000 prescriptions were covered by Medi-Cal across all uses of the medications